Patients must be at least 18 years old and meet one of the following clinical requirements when GLP-1 therapy begins: A body mass index, or BMI, of 35 or higher A BMI between 30 and 34.99 with at least one qualifying health condition A BMI between 27 and 29.99 with at least one qualifying higher-risk health condition For someone with a BMI between 30 and 34.99, qualifying conditions may include heart failure with preserved ejection fraction, uncontrolled high blood pressure, stage 3a or higher chronic kidney disease, prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease
After an injury, many cell types must travel to the site: immune cells to clear debris, fibroblasts to build new connective tissue, endothelial cells to form blood vessels, and stem cells to differentiate
IPTB-risk was graded as severe (cervix length 10 mm) or moderate (cervix length 1020 mm) with preterm uterine contractions
and the two papers disagree on tirzepatides albumin shift at GIPR (26 vs 163), an unresolved discrepancy at the primary-source level
The Circadian 12-Hour Fast (The Only IF Allowed) The only form of Intermittent Fasting universally recommended by clinical endocrinologists for patients on GLP-1 therapy is the simple, natural 12-hour overnight fast
Making a few simple swaps in your menu can ensure youre getting enough nutrients, maintain muscle mass, and support steady energy levels throughout the day